Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT and Harmine with Mindfulness in Experienced Meditators
NCT05780216Phase 1Completed
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing DMT + Harmine with Placebo (2 arms). Primary endpoint: Functional brain connectivity changes in response to DMT-enhanced mindfulness in experienced meditators (rs-fMRI). Started Feb 2023; status: completed.
02
Drugs
DMTharmine
Beyond the preview
Go deeper on NCT05780216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05780216.